New Delhi, Jun 26: The Regional Centre for Biotechnology (RCB), an academic institution of national importance established by the Department of Biotechnology, under the auspices of UNESCO, and GlaxoSmithKline Pharmaceuticals Ltd on Wednesday launched the Trust in Science programme to develop doctoral programs (PhDs) in the fields of biostatistics and bioinformatics.
The launch took place in the presence of Dr Renu Swarup, Secretary, Department of Biotechnology, Dominic Asquith KCMG, British High Commissioner to India, Sudhanshu Vrati, Executive Director, RCB, and A Vaidheesh, Vice President, & MD, GSK Pharmaceutical Ltd.
Under this initiative, the RCB will develop program content, manage logistics and oversee the running of the full-time programs. GSK Pharmaceutical Ltd. will provide funding and ensure all course content is shaped to address current industry needs and opportunities. Students with a master’s degree in biostatistics, maths, and bioinformatics are eligible for the PhD courses.
GSK Pharmaceutical Ltd.’s “Trust in Science” initiative is a novel public-private partnership model to build research and development capacity for development and discovery in science. The pillars of this initiative are: scientific excellence, trust and talent development in line with GSK’s Science, Technology and Culture values. (UNI)